Elevated interleukin-1beta in pericardial fluid of patients with ischemic heart disease

J Oyama1, H Shimokawa, S Morita

  • 1Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

Coronary Artery Disease
|November 21, 2001
PubMed

Insights

Elevated interleukin-1 beta in pericardial fluid indicates greater ischemic heart disease extent. This cytokine may also directly contribute to coronary atherosclerosis progression.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Biochemistry

Background:

  • Inflammatory cytokines are implicated in atherosclerosis and heart failure pathogenesis.
  • Interleukin-1 beta (IL-1β) treatment promotes coronary arteriosclerosis and impairs cardiac function.
  • Pericardial fluid cytokines may indicate coronary atherosclerosis severity and promote its progression.

Purpose of the Study:

  • To investigate the significance of cytokine concentrations in pericardial fluid of cardiovascular disease patients.
  • To assess the relationship between pericardial cytokines and specific heart conditions.

Main Methods:

  • Measured 10 major cytokines in pericardial fluid from 56 patients undergoing open heart surgery.
  • Patients were categorized into ischemic heart disease (IHD), valvular heart disease (VHD), and congenital heart disease (CHD) groups.

Main Results:

  • Pericardial IL-1β concentrations were significantly higher in the IHD group compared to VHD and CHD groups (P < 0.05).
  • No significant differences in other cytokine levels were observed among groups.
  • In the IHD group, elevated IL-1β was noted in patients with emergency operations or unstable angina.

Conclusions:

  • Pericardial IL-1β concentrations may serve as a marker for the extent of ischemic heart disease.
  • Elevated IL-1β in pericardial fluid could directly contribute to the progression of coronary atherosclerosis.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.